DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Van Cutsem E et al.
Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.
Journal of Clinical Oncology 2009;
27 (13) 2231-2237
We do not assume any responsibility for the contents of the web pages of other providers.